FDA Inspection 1165427 — MolecularMD Corp
The FDA completed an inspection of MolecularMD Corp on Mar 2, 2022 in Portland, OR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 2, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Portland, OR (United States)